Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Insilico Medicine's ISM8969 Nears Clinical Evaluation for Parkinson's Disease
CompanyDrug

Insilico Medicine’s ISM8969 Nears Clinical Evaluation for Parkinson’s Disease

August 15, 2025
SineuGene's First-in-Class ALS Gene Therapy SNUG01 Gets NMPA Clinical Trial Clearance
CompanyDrug

SineuGene’s First-in-Class ALS Gene Therapy SNUG01 Gets NMPA Clinical Trial Clearance

August 15, 2025
Fosun Pharma Issues China's First Private Pharma Innovation Bond to Accelerate R&D
CompanyDeals

Fosun Pharma Issues China’s First Private Pharma Innovation Bond to Accelerate R&D

August 15, 2025
Lilly Hikes Mounjaro Price in UK by 170% for Private-Pay Patients
CompanyDrug

Eli Lilly Hikes Mounjaro Price in UK by 170% for Private-Pay Patients

August 15, 2025
Qihan Biotech's QT-019B Gains FDA IND Approval for Autoimmune Diseases
CompanyDrug

Qihan Biotech’s QT-019B Gains FDA IND Approval for Autoimmune Diseases

August 15, 2025
Novartis' Ianalumab Shows Positive Results in Phase 3 Trials for ITP and Sjögren's Disease
CompanyDrug

Novartis’ Ianalumab Shows Positive Results in Phase 3 Trials for ITP and Sjögren’s Disease

August 14, 2025
Everest Medicines' Velsipity NDA Accepted for Review in Taiwan
CompanyDrug

Everest Medicines’ Velsipity NDA Accepted for Review in Taiwan

August 14, 2025
Hualan Biological Gains NMPA Approval for Hib Vaccine Clinical Trials
CompanyDrug

Hualan Biological Gains NMPA Approval for Hib Vaccine Clinical Trials

August 14, 2025
RemeGen Announces Positive Phase III Results for Telitacicept in Primary Sjögren's Syndrome
CompanyDrug

RemeGen Announces Positive Phase III Results for Telitacicept in Primary Sjögren’s Syndrome

August 14, 2025
China Issues Guidelines for Medical Advertisement Identification, Clarifies Scenarios and Regulations
HospitalMedical Device

China Issues Guidelines for Medical Advertisement Identification, Clarifies Scenarios and Regulations

August 14, 2025
MSD Officially Launches Zerbaxa in China to Tackle Drug-Resistant Infections
CompanyDrug

MSD Officially Launches Zerbaxa in China to Tackle Drug-Resistant Infections

August 14, 2025
Jiangsu Hengrui Establishes New Biopharmaceutical Unit to Strengthen Anesthesia and ICU Presence
Company

Jiangsu Hengrui Establishes New Biopharmaceutical Unit to Strengthen Anesthesia and ICU Presence

August 14, 2025
1 2 … 9 10 11 12 13 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up